NALPAIN

This brand name is authorized in Estonia, France, Poland

Active ingredients

The drug NALPAIN contains one active pharmaceutical ingredient (API):

1 Nalbuphine UNII ZU4275277R - NALBUPHINE HYDROCHLORIDE

Nalbuphine is an opioid with kappa-agonistic and mu-antagonistic properties. Beside the essential agonistic (analgesic) effect nalbuphine has antagonistic effects of about a fourth of nalorfine and ten times of pentazocine. Read about Nalbuphine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NALPAIN Solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N02AF02	Nalbuphine	N Nervous system → N02 Analgesics → N02A Opioids → N02AF Morphinan derivatives
Discover more medicines within N02AF02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1275724
Country: FR	Base de données publique des médicaments	Identifier(s): 66352301
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100191043